pembrolizumab,medi-5752
astrazeneca,merck
['keytruda', '$azn', '$mrk', 'astrazeneca']
esmo: astrazeneca s checkpoint inhibitor bispecific may rival keytruda, but dose change leaves questions! $azn $mrk #immunooncology #esmo2022 
Investor Relations & PR firm working w/ growth #LifeSciences #Tech #Mining #Consumer companies to connect #WallStreet #Investors — No investment advice / DYODD